period ended 31 March 2018, and the information memorandum regarding an acquisition of assets, disclosed on 27 February 2018.) Performance Summary Total Revenues In 1Q18, Singha Estate reported

our gross margin, as well as, our effort in managing SG&A. T.662 636 6999 F.662 646 4200

10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th Financial Position As at December 31 Change 2019 2018 MB MB MB % Total assets 525.87 195.47 330.40 169.03 Total liabilities 60.13

, Suriyawong, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th Financial Position As at December 31 Change 2019 2018 MB MB MB % Total assets 525.87 195.47 330.40 169.03

. Financial Position As at December 31 Change 2019 2018 MB MB MB % Total assets 525.87 195.47 330.40 169.03 Total liabilities 60.13 88.48 (28.35) (32.04) Total shareholders’ equity 465.74 106.99 358.75 335.31

Baht) 2017 2016 Inc./(Dec.) % Current Assets 220.09 189.91 30.18 15.89 Non-Current Assets 273.02 278.47 -5.45 -1.96 Total Assets 493.11 468.38 24.73 5.28 Current Liabilities 285.67 243.80 41.87 17.17 Non

% Total assets 1,862.28 2,060.09 -197.80 -9.60% Total liabilities 1,071.05 1,255.62 -184.58 -14.70% Total shareholders’ equity 791.24 804.46 -13.23 -1.64% As at March 31, 2016, the Company and its

ccounts receiv ther long-term quipment otal non-curre otal Assets abilities and S hort-term loan stitutions rade and othe urrent portion hort-term loan otal current lia ong-term loans ebentures - ne otal

, increased by Baht 244.40 million or 10.06% due to factors as summarized below ; Total Assets As at 30 September 2017, total assets was Baht 2,673.13 million, increased by Baht 244.40 million from the ended 31

Differentiate MB THB % Total Assets 6,758.4 11,121.3 4,362.9 64.56 Total Liabilities 4,014.9 7,502.8 3,487.9 86.87 Total Shareholders’ Equity 2,743.5 3,618.5 875.0 31.89 หน้า 5 ของ 5 Total Assets of The Group as